Fang Jiang - 18 Mar 2026 Form 3 Insider Report for Alibaba Group Holding Ltd (BABA)

Role
Chief People Officer
Signature
/s/ Kevin Jinwei Zhang, as Attorney-in-Fact for Fang Jiang
Issuer symbol
BABA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:20:43 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jiang Fang Chief People Officer 26/F TOWER ONE, TIMES SQUARE, 1 MATHESON STREET, CAUSEWAY BAY, HONG KONG, HONG KONG /s/ Kevin Jinwei Zhang, as Attorney-in-Fact for Fang Jiang 18 Mar 2026 0002114927

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BABA Ordinary Shares 5,534,168 18 Mar 2026 Direct
holding BABA Ordinary Shares 23,116,864 18 Mar 2026 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 2,672 Direct F1, F2
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 14,936 Direct F2, F3
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 31,600 Direct F2, F4
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 42,672 Direct F2, F5
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 28,336 Direct F2, F6
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 28,334 Direct F7, F8
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 56,000 Direct F8, F9
holding BABA Option (right to buy) 18 Mar 2026 Ordinary Shares 160,000 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of American Depository Shares ("ADSs") that vests in six equal annual installments beginning on Apr 1, 2021, subject to the terms and conditions of the underlying award agreement.
F2 Each restricted share unit represents a contingent right to receive one ADS. Each ADS represents 8 ordinary shares. This amount represents the ordinary shares underlying the ADSs in this award.
F3 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2022, subject to the terms and conditions of the underlying award agreement.
F4 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2023, subject to the terms and conditions of the underlying award agreement.
F5 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2024, subject to the terms and conditions of the underlying award agreement.
F6 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in twenty-four equal quarterly installments beginning on Jul 1, 2024, subject to the terms and conditions of the underlying award agreement.
F7 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-one quarterly installments, with 1/6 vesting on Jul 1, 2025 and 1/24 quarterly thereafter beginning on Oct 1, 2025, subject to the terms and conditions of the underlying award agreement
F8 Each restricted share unit represents a contingent right to receive one ordinary share.
F9 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-four equal quarterly installments on beginning on Jul 1, 2025, subject to the terms and conditions of the underlying award agreement.
F10 Reflects an option award granted in the form of ordinary shares that vests 40% in the second year and then 30% each in the third year and the fourth year beginning on Mar 1, 2027, subject to the terms and conditions of the underlying award agreement.
F11 The exercise price of this option is HK$68 per ordinary share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$68 to US$8.72.